MannKind Corporation

Financials

Flujo de caja de las actividades operativas -28.13 M-61.71 M-80.68 M34.09 M42.51 M18.25 M 18.25 M Flujo de caja de las actividades de inversión 15.22 M-151.54 M4.87 M-1.99 M-96.65 M-304.8 M -304.8 M Flujo de caja de las actividades financieras 49.85 M270.27 M21.39 M136.61 M-137.27 M315.1 M 315.1 M Flujo de caja libre -28.93 M-73.17 M-88.27 M-8.35 M32.82 M13.69 M 13.69 M

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.

MNKD

Financials

MannKind Corporation

Noticias

Leerink reitera Mejor Rendimiento en acciones de MannKind, ve sobrereacción

Truist reitera calificación de MannKind tras datos de ensayo

MannKind: Strategic Uncertainty Follows United Therapeutics’ Pivot (NASDAQ:MNKD)

MannKind en la Conferencia de Salud de Barclays: Crecimiento Estratégico e Innovación

MannKind en Conferencia de Salud Barclays: Crecimiento e Innovación

MannKind at Barclays Healthcare Conference: Strategic Growth and Innovation

MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

MannKind en Leerink Global Healthcare: Expandiendo horizontes

MannKind en Leerink Global Healthcare: Expandiendo horizontes en farmacia

MannKind at Leerink Global Healthcare: Expanding Horizons in Pharma

MannKind presenta datos de Afrezza en conferencia sobre diabetes

MannKind presenta datos de Afrezza en conferencia sobre diabetes